Compare Tempo Scan Pacific Tbk. (TSPC) vs Zyrexindo Mandiri Buana Tbk. (ZYRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempo Scan Pacific Tbk. vs Zyrexindo Mandiri Buana Tbk. — how do they compare? Tempo Scan Pacific Tbk. trades at Rp2,800 (market cap 12.54T, 323.8K 24h volume), while Zyrexindo Mandiri Buana Tbk. trades at Rp129 (market cap 178.67B, 949.3K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 70.2× Zyrexindo Mandiri Buana Tbk.'s market cap, and Zyrexindo Mandiri Buana Tbk. is more actively traded (949.3K versus 323.8K). Which is the better fit depends on your goals.
| TSPC | ZYRX | |
|---|---|---|
Market Cap | 12.54T | 178.67B |
Volume | 323.8K | 949.3K |
Lot | 3.24K | 9.49K |
Turnover | 902.58M | 122.87M |
Average Price | 2,787.45 | 129.43 |
Value | 902.58M | 122.87M |
Indicative Equilibrium Price | 2,800 | 129 |
Indicative Equilibrium Volume | 551 | 48 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →About Zyrexindo Mandiri Buana Tbk.
PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Read more on ZYRX →
